# Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension

> **NCT00061503** · PHASE4 · COMPLETED · sponsor: **Alcon Research**

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost

## Key facts

- **NCT ID:** NCT00061503
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2004-03
- **Final completion:** 2004-03
- **Target enrollment:** — (—)
- **Last updated:** 2008-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00061503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00061503, "Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00061503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*